✦ LIBER ✦

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

✍ Scribed by Jeffrey S. Berger; Deepak L. Bhatt; P. Gabriel Steg; Steven R. Steinhubl; Gilles Montalescot; Mingyuan Shao; Werner Hacke; Keith A. Fox; Peter B. Berger; Eric J. Topol; A. Michael Lincoff

Book ID: 116192504
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 327 KB
Volume: 162
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2011.04.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding, mortality, and antiplatelet th

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

✍ Saurav Chatterjee; Subhankar Maitra; Anasua Chakraborty 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Reply to the letter by Chatterjee et al

Reply to the letter by Chatterjee et al “Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial”

✍ Jeffery S. Berger; Deepak L. Bhatt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Bleeding Complications With Dual Antipla

Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease: Results From the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Trial

✍ P.B. Berger; D.L. Bhatt; V. Fuster 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 67 KB

A global view of atherothrombosis: Basel

A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

✍ Deepak L. Bhatt; Keith A. Fox; Werner Hacke; Peter B. Berger; Henry R. Black; Wi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Ethnic variation in adverse cardiovascul

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study

✍ Koon-Hou Mak; Deepak L. Bhatt; Mingyuan Shao; Graeme J. Hankey; J. Donald Easton 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Clopidogrel added to aspirin versus aspi

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

✍ Deepak L. Bhatt; Eric J. Topol 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 112 KB